摘要
Abstract
Objective To research the method for improving the effectiveness in treating senile acute leukemia. Methods 78 patients with senile acute leukemia were divided into the observation group and the control group with 39 cases in each group. The observation group was treated with the CAG scheme combined with Shenmai Injection, while the control group only adopted the CAG scheme. The clinical data after treatment in the two groups were statistically analyzed. Results The total effective rate after treatment was 87. 18%in the observation group, which was obviously higher than 84. 62% in the control group, but the difference between the two groups had no statistical significance (χ2=0. 519, P=0. 820> 0. 05 ) . Moreover, no statistically significant differences in the indexes of WBC and hemoglobin were found between the two groups ( P>0. 05 ) , while the indexes of RBC and platelet had statistically significantly differ-ences (χ2=6. 639, P<0. 05, χ2=6. 587, P<0. 05 ) . The two groups had statistically significant differences in the aspect of clinical toxic and side effects ( P<0. 05 ) . Conclusion The CAG scheme combined Shenmai Injection has a good therapeutic effect in treating senile acute leukemia. In the clinical treatment, the dosage should be decreased for the patients with high age and hypoimmunity. At the same time more attention should be paid to the nursing care and infection prevention in order to improve the therapeutic effect and prolong the survival period of patients.关键词
老年急性白血病/参麦注射液/化学治疗Key words
senile acute leukemia/Shenmai Injection/chemotherapy分类
医药卫生
